nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—UGT1A1—Pazopanib—kidney cancer	0.179	0.333	CbGbCtD
Ezogabine—UGT1A1—Erlotinib—kidney cancer	0.127	0.238	CbGbCtD
Ezogabine—UGT1A9—Sorafenib—kidney cancer	0.127	0.236	CbGbCtD
Ezogabine—UGT1A1—Sorafenib—kidney cancer	0.104	0.193	CbGbCtD
Ezogabine—NAT2—urine—kidney cancer	0.0288	0.4	CbGeAlD
Ezogabine—UGT1A1—urine—kidney cancer	0.0107	0.148	CbGeAlD
Ezogabine—NAT2—renal system—kidney cancer	0.00706	0.0978	CbGeAlD
Ezogabine—UGT1A4—renal system—kidney cancer	0.00455	0.0631	CbGeAlD
Ezogabine—UGT1A4—kidney—kidney cancer	0.0044	0.061	CbGeAlD
Ezogabine—KCNQ2—gonad—kidney cancer	0.00397	0.0551	CbGeAlD
Ezogabine—UGT1A9—renal system—kidney cancer	0.00381	0.0528	CbGeAlD
Ezogabine—UGT1A9—kidney—kidney cancer	0.00368	0.0511	CbGeAlD
Ezogabine—UGT1A1—renal system—kidney cancer	0.00261	0.0362	CbGeAlD
Ezogabine—UGT1A1—kidney—kidney cancer	0.00252	0.035	CbGeAlD
Ezogabine—Malaise—Dactinomycin—kidney cancer	0.000421	0.00173	CcSEcCtD
Ezogabine—Mental disorder—Vincristine—kidney cancer	0.00042	0.00173	CcSEcCtD
Ezogabine—Leukopenia—Dactinomycin—kidney cancer	0.000418	0.00172	CcSEcCtD
Ezogabine—Liver function test abnormal—Capecitabine—kidney cancer	0.000417	0.00171	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Everolimus—kidney cancer	0.000416	0.00171	CcSEcCtD
Ezogabine—Infection—Sorafenib—kidney cancer	0.000416	0.00171	CcSEcCtD
Ezogabine—Fatigue—Everolimus—kidney cancer	0.000416	0.00171	CcSEcCtD
Ezogabine—Dyspnoea—Erlotinib—kidney cancer	0.000415	0.0017	CcSEcCtD
Ezogabine—Constipation—Vinblastine—kidney cancer	0.000414	0.0017	CcSEcCtD
Ezogabine—Constipation—Everolimus—kidney cancer	0.000413	0.00169	CcSEcCtD
Ezogabine—Shock—Sorafenib—kidney cancer	0.000412	0.00169	CcSEcCtD
Ezogabine—Gait disturbance—Doxorubicin—kidney cancer	0.000411	0.00169	CcSEcCtD
Ezogabine—Dry mouth—Sunitinib—kidney cancer	0.000411	0.00169	CcSEcCtD
Ezogabine—Nervous system disorder—Sorafenib—kidney cancer	0.000411	0.00169	CcSEcCtD
Ezogabine—Thrombocytopenia—Sorafenib—kidney cancer	0.00041	0.00168	CcSEcCtD
Ezogabine—Dyspepsia—Erlotinib—kidney cancer	0.00041	0.00168	CcSEcCtD
Ezogabine—Rash—Temsirolimus—kidney cancer	0.000409	0.00168	CcSEcCtD
Ezogabine—Coordination abnormal—Doxorubicin—kidney cancer	0.000409	0.00168	CcSEcCtD
Ezogabine—Dermatitis—Temsirolimus—kidney cancer	0.000409	0.00168	CcSEcCtD
Ezogabine—Haematuria—Paclitaxel—kidney cancer	0.000405	0.00166	CcSEcCtD
Ezogabine—Dizziness—Pazopanib—kidney cancer	0.000404	0.00166	CcSEcCtD
Ezogabine—Alopecia—Gemcitabine—kidney cancer	0.000402	0.00165	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000402	0.00165	CcSEcCtD
Ezogabine—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000401	0.00165	CcSEcCtD
Ezogabine—Fatigue—Erlotinib—kidney cancer	0.000401	0.00165	CcSEcCtD
Ezogabine—Infection—Sunitinib—kidney cancer	0.0004	0.00164	CcSEcCtD
Ezogabine—Feeling abnormal—Vinblastine—kidney cancer	0.000399	0.00164	CcSEcCtD
Ezogabine—Constipation—Erlotinib—kidney cancer	0.000398	0.00163	CcSEcCtD
Ezogabine—Feeling abnormal—Everolimus—kidney cancer	0.000398	0.00163	CcSEcCtD
Ezogabine—Shock—Sunitinib—kidney cancer	0.000396	0.00163	CcSEcCtD
Ezogabine—Nervous system disorder—Sunitinib—kidney cancer	0.000395	0.00162	CcSEcCtD
Ezogabine—Thrombocytopenia—Sunitinib—kidney cancer	0.000395	0.00162	CcSEcCtD
Ezogabine—Discomfort—Dactinomycin—kidney cancer	0.000393	0.00161	CcSEcCtD
Ezogabine—Influenza—Capecitabine—kidney cancer	0.000391	0.0016	CcSEcCtD
Ezogabine—Dysphagia—Capecitabine—kidney cancer	0.000391	0.0016	CcSEcCtD
Ezogabine—Rash—Pazopanib—kidney cancer	0.000385	0.00158	CcSEcCtD
Ezogabine—Nausea—Temsirolimus—kidney cancer	0.000385	0.00158	CcSEcCtD
Ezogabine—Dermatitis—Pazopanib—kidney cancer	0.000385	0.00158	CcSEcCtD
Ezogabine—Infection—Dactinomycin—kidney cancer	0.000379	0.00156	CcSEcCtD
Ezogabine—Urinary tract disorder—Paclitaxel—kidney cancer	0.000376	0.00154	CcSEcCtD
Ezogabine—Oedema peripheral—Paclitaxel—kidney cancer	0.000375	0.00154	CcSEcCtD
Ezogabine—Vertigo—Vincristine—kidney cancer	0.000375	0.00154	CcSEcCtD
Ezogabine—Leukopenia—Vincristine—kidney cancer	0.000374	0.00153	CcSEcCtD
Ezogabine—Urethral disorder—Paclitaxel—kidney cancer	0.000373	0.00153	CcSEcCtD
Ezogabine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000373	0.00153	CcSEcCtD
Ezogabine—Dyspnoea—Sorafenib—kidney cancer	0.000373	0.00153	CcSEcCtD
Ezogabine—Dyspepsia—Sorafenib—kidney cancer	0.000369	0.00151	CcSEcCtD
Ezogabine—Ill-defined disorder—Gemcitabine—kidney cancer	0.000368	0.00151	CcSEcCtD
Ezogabine—Visual impairment—Paclitaxel—kidney cancer	0.000367	0.00151	CcSEcCtD
Ezogabine—Coma—Doxorubicin—kidney cancer	0.000367	0.00151	CcSEcCtD
Ezogabine—Dysuria—Capecitabine—kidney cancer	0.000365	0.0015	CcSEcCtD
Ezogabine—Neutropenia—Capecitabine—kidney cancer	0.000365	0.0015	CcSEcCtD
Ezogabine—Nausea—Pazopanib—kidney cancer	0.000363	0.00149	CcSEcCtD
Ezogabine—Paraesthesia—Sunitinib—kidney cancer	0.000362	0.00149	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000362	0.00148	CcSEcCtD
Ezogabine—Fatigue—Sorafenib—kidney cancer	0.000361	0.00148	CcSEcCtD
Ezogabine—Dyspnoea—Sunitinib—kidney cancer	0.000359	0.00147	CcSEcCtD
Ezogabine—Constipation—Sorafenib—kidney cancer	0.000358	0.00147	CcSEcCtD
Ezogabine—Malaise—Gemcitabine—kidney cancer	0.000357	0.00147	CcSEcCtD
Ezogabine—Eye disorder—Paclitaxel—kidney cancer	0.000356	0.00146	CcSEcCtD
Ezogabine—Weight increased—Capecitabine—kidney cancer	0.000355	0.00146	CcSEcCtD
Ezogabine—Dyspepsia—Sunitinib—kidney cancer	0.000355	0.00146	CcSEcCtD
Ezogabine—Leukopenia—Gemcitabine—kidney cancer	0.000355	0.00146	CcSEcCtD
Ezogabine—Infestation NOS—Capecitabine—kidney cancer	0.000348	0.00143	CcSEcCtD
Ezogabine—Infestation—Capecitabine—kidney cancer	0.000348	0.00143	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000348	0.00143	CcSEcCtD
Ezogabine—Asthenia—Vinblastine—kidney cancer	0.000347	0.00143	CcSEcCtD
Ezogabine—Fatigue—Sunitinib—kidney cancer	0.000347	0.00143	CcSEcCtD
Ezogabine—Asthenia—Everolimus—kidney cancer	0.000346	0.00142	CcSEcCtD
Ezogabine—Constipation—Sunitinib—kidney cancer	0.000345	0.00141	CcSEcCtD
Ezogabine—Infection—Vincristine—kidney cancer	0.000339	0.00139	CcSEcCtD
Ezogabine—Alopecia—Paclitaxel—kidney cancer	0.000337	0.00138	CcSEcCtD
Ezogabine—Nervous system disorder—Vincristine—kidney cancer	0.000334	0.00137	CcSEcCtD
Ezogabine—Asthenia—Erlotinib—kidney cancer	0.000334	0.00137	CcSEcCtD
Ezogabine—Mental disorder—Paclitaxel—kidney cancer	0.000334	0.00137	CcSEcCtD
Ezogabine—Thrombocytopenia—Vincristine—kidney cancer	0.000334	0.00137	CcSEcCtD
Ezogabine—Discomfort—Gemcitabine—kidney cancer	0.000333	0.00137	CcSEcCtD
Ezogabine—Haematuria—Capecitabine—kidney cancer	0.000332	0.00136	CcSEcCtD
Ezogabine—Malnutrition—Paclitaxel—kidney cancer	0.000332	0.00136	CcSEcCtD
Ezogabine—Hyperhidrosis—Vincristine—kidney cancer	0.000329	0.00135	CcSEcCtD
Ezogabine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000329	0.00135	CcSEcCtD
Ezogabine—Fatigue—Dactinomycin—kidney cancer	0.000329	0.00135	CcSEcCtD
Ezogabine—Infection—Gemcitabine—kidney cancer	0.000321	0.00132	CcSEcCtD
Ezogabine—Dizziness—Vinblastine—kidney cancer	0.00032	0.00131	CcSEcCtD
Ezogabine—Dizziness—Everolimus—kidney cancer	0.000319	0.00131	CcSEcCtD
Ezogabine—Muscle spasms—Paclitaxel—kidney cancer	0.000319	0.00131	CcSEcCtD
Ezogabine—Nervous system disorder—Gemcitabine—kidney cancer	0.000317	0.0013	CcSEcCtD
Ezogabine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000317	0.0013	CcSEcCtD
Ezogabine—Feeling abnormal—Dactinomycin—kidney cancer	0.000314	0.00129	CcSEcCtD
Ezogabine—Vision blurred—Paclitaxel—kidney cancer	0.000313	0.00128	CcSEcCtD
Ezogabine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000313	0.00128	CcSEcCtD
Ezogabine—Tremor—Paclitaxel—kidney cancer	0.000311	0.00128	CcSEcCtD
Ezogabine—Increased appetite—Doxorubicin—kidney cancer	0.00031	0.00127	CcSEcCtD
Ezogabine—Urinary tract disorder—Capecitabine—kidney cancer	0.000309	0.00127	CcSEcCtD
Ezogabine—Oedema peripheral—Capecitabine—kidney cancer	0.000308	0.00126	CcSEcCtD
Ezogabine—Dizziness—Erlotinib—kidney cancer	0.000308	0.00126	CcSEcCtD
Ezogabine—Ill-defined disorder—Paclitaxel—kidney cancer	0.000308	0.00126	CcSEcCtD
Ezogabine—Urethral disorder—Capecitabine—kidney cancer	0.000306	0.00126	CcSEcCtD
Ezogabine—Paraesthesia—Vincristine—kidney cancer	0.000306	0.00126	CcSEcCtD
Ezogabine—Rash—Everolimus—kidney cancer	0.000304	0.00125	CcSEcCtD
Ezogabine—Dermatitis—Everolimus—kidney cancer	0.000304	0.00125	CcSEcCtD
Ezogabine—Visual impairment—Capecitabine—kidney cancer	0.000301	0.00124	CcSEcCtD
Ezogabine—Asthenia—Sorafenib—kidney cancer	0.0003	0.00123	CcSEcCtD
Ezogabine—Malaise—Paclitaxel—kidney cancer	0.000299	0.00123	CcSEcCtD
Ezogabine—Vertigo—Paclitaxel—kidney cancer	0.000298	0.00122	CcSEcCtD
Ezogabine—Syncope—Paclitaxel—kidney cancer	0.000297	0.00122	CcSEcCtD
Ezogabine—Leukopenia—Paclitaxel—kidney cancer	0.000297	0.00122	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000294	0.00121	CcSEcCtD
Ezogabine—Fatigue—Vincristine—kidney cancer	0.000294	0.00121	CcSEcCtD
Ezogabine—Rash—Erlotinib—kidney cancer	0.000293	0.0012	CcSEcCtD
Ezogabine—Dermatitis—Erlotinib—kidney cancer	0.000293	0.0012	CcSEcCtD
Ezogabine—Eye disorder—Capecitabine—kidney cancer	0.000292	0.0012	CcSEcCtD
Ezogabine—Loss of consciousness—Paclitaxel—kidney cancer	0.000292	0.0012	CcSEcCtD
Ezogabine—Constipation—Vincristine—kidney cancer	0.000291	0.0012	CcSEcCtD
Ezogabine—Diplopia—Doxorubicin—kidney cancer	0.000291	0.0012	CcSEcCtD
Ezogabine—Osteoarthritis—Doxorubicin—kidney cancer	0.000291	0.0012	CcSEcCtD
Ezogabine—Paraesthesia—Gemcitabine—kidney cancer	0.00029	0.00119	CcSEcCtD
Ezogabine—Asthenia—Sunitinib—kidney cancer	0.000289	0.00119	CcSEcCtD
Ezogabine—Dyspnoea—Gemcitabine—kidney cancer	0.000288	0.00118	CcSEcCtD
Ezogabine—Nausea—Vinblastine—kidney cancer	0.000288	0.00118	CcSEcCtD
Ezogabine—Somnolence—Gemcitabine—kidney cancer	0.000287	0.00118	CcSEcCtD
Ezogabine—Nausea—Everolimus—kidney cancer	0.000287	0.00118	CcSEcCtD
Ezogabine—Anxiety—Paclitaxel—kidney cancer	0.000281	0.00116	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000279	0.00115	CcSEcCtD
Ezogabine—Discomfort—Paclitaxel—kidney cancer	0.000279	0.00115	CcSEcCtD
Ezogabine—Fatigue—Gemcitabine—kidney cancer	0.000279	0.00114	CcSEcCtD
Ezogabine—Dizziness—Sorafenib—kidney cancer	0.000277	0.00114	CcSEcCtD
Ezogabine—Constipation—Gemcitabine—kidney cancer	0.000276	0.00113	CcSEcCtD
Ezogabine—Nausea—Erlotinib—kidney cancer	0.000276	0.00113	CcSEcCtD
Ezogabine—Alopecia—Capecitabine—kidney cancer	0.000276	0.00113	CcSEcCtD
Ezogabine—Dry mouth—Paclitaxel—kidney cancer	0.000276	0.00113	CcSEcCtD
Ezogabine—Mental disorder—Capecitabine—kidney cancer	0.000274	0.00112	CcSEcCtD
Ezogabine—Asthenia—Dactinomycin—kidney cancer	0.000274	0.00112	CcSEcCtD
Ezogabine—Confusional state—Paclitaxel—kidney cancer	0.000273	0.00112	CcSEcCtD
Ezogabine—Malnutrition—Capecitabine—kidney cancer	0.000272	0.00112	CcSEcCtD
Ezogabine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000269	0.0011	CcSEcCtD
Ezogabine—Infection—Paclitaxel—kidney cancer	0.000269	0.0011	CcSEcCtD
Ezogabine—Dizziness—Sunitinib—kidney cancer	0.000266	0.00109	CcSEcCtD
Ezogabine—Feeling abnormal—Gemcitabine—kidney cancer	0.000266	0.00109	CcSEcCtD
Ezogabine—Shock—Paclitaxel—kidney cancer	0.000266	0.00109	CcSEcCtD
Ezogabine—Nervous system disorder—Paclitaxel—kidney cancer	0.000265	0.00109	CcSEcCtD
Ezogabine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000265	0.00109	CcSEcCtD
Ezogabine—Rash—Sorafenib—kidney cancer	0.000264	0.00108	CcSEcCtD
Ezogabine—Dermatitis—Sorafenib—kidney cancer	0.000264	0.00108	CcSEcCtD
Ezogabine—Muscle spasms—Capecitabine—kidney cancer	0.000262	0.00107	CcSEcCtD
Ezogabine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000262	0.00107	CcSEcCtD
Ezogabine—Vision blurred—Capecitabine—kidney cancer	0.000257	0.00105	CcSEcCtD
Ezogabine—Tremor—Capecitabine—kidney cancer	0.000255	0.00105	CcSEcCtD
Ezogabine—Rash—Sunitinib—kidney cancer	0.000254	0.00104	CcSEcCtD
Ezogabine—Dermatitis—Sunitinib—kidney cancer	0.000254	0.00104	CcSEcCtD
Ezogabine—Ill-defined disorder—Capecitabine—kidney cancer	0.000253	0.00104	CcSEcCtD
Ezogabine—Dysphagia—Doxorubicin—kidney cancer	0.000252	0.00103	CcSEcCtD
Ezogabine—Influenza—Doxorubicin—kidney cancer	0.000252	0.00103	CcSEcCtD
Ezogabine—Nausea—Sorafenib—kidney cancer	0.000249	0.00102	CcSEcCtD
Ezogabine—Malaise—Capecitabine—kidney cancer	0.000245	0.00101	CcSEcCtD
Ezogabine—Vertigo—Capecitabine—kidney cancer	0.000245	0.001	CcSEcCtD
Ezogabine—Asthenia—Vincristine—kidney cancer	0.000245	0.001	CcSEcCtD
Ezogabine—Syncope—Capecitabine—kidney cancer	0.000244	0.001	CcSEcCtD
Ezogabine—Leukopenia—Capecitabine—kidney cancer	0.000244	0.001	CcSEcCtD
Ezogabine—Paraesthesia—Paclitaxel—kidney cancer	0.000243	0.000998	CcSEcCtD
Ezogabine—Dyspnoea—Paclitaxel—kidney cancer	0.000241	0.000991	CcSEcCtD
Ezogabine—Somnolence—Paclitaxel—kidney cancer	0.000241	0.000988	CcSEcCtD
Ezogabine—Rash—Dactinomycin—kidney cancer	0.000241	0.000987	CcSEcCtD
Ezogabine—Nausea—Sunitinib—kidney cancer	0.000239	0.000982	CcSEcCtD
Ezogabine—Loss of consciousness—Capecitabine—kidney cancer	0.000239	0.000982	CcSEcCtD
Ezogabine—Dyspepsia—Paclitaxel—kidney cancer	0.000238	0.000978	CcSEcCtD
Ezogabine—Dysuria—Doxorubicin—kidney cancer	0.000235	0.000967	CcSEcCtD
Ezogabine—Neutropenia—Doxorubicin—kidney cancer	0.000235	0.000967	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000234	0.000959	CcSEcCtD
Ezogabine—Fatigue—Paclitaxel—kidney cancer	0.000233	0.000958	CcSEcCtD
Ezogabine—Asthenia—Gemcitabine—kidney cancer	0.000232	0.000952	CcSEcCtD
Ezogabine—Constipation—Paclitaxel—kidney cancer	0.000231	0.00095	CcSEcCtD
Ezogabine—Anxiety—Capecitabine—kidney cancer	0.000231	0.000948	CcSEcCtD
Ezogabine—Weight increased—Doxorubicin—kidney cancer	0.000229	0.000941	CcSEcCtD
Ezogabine—Discomfort—Capecitabine—kidney cancer	0.000229	0.00094	CcSEcCtD
Ezogabine—Dry mouth—Capecitabine—kidney cancer	0.000227	0.00093	CcSEcCtD
Ezogabine—Nausea—Dactinomycin—kidney cancer	0.000227	0.00093	CcSEcCtD
Ezogabine—Dizziness—Vincristine—kidney cancer	0.000225	0.000925	CcSEcCtD
Ezogabine—Infestation NOS—Doxorubicin—kidney cancer	0.000225	0.000922	CcSEcCtD
Ezogabine—Infestation—Doxorubicin—kidney cancer	0.000225	0.000922	CcSEcCtD
Ezogabine—Confusional state—Capecitabine—kidney cancer	0.000224	0.000919	CcSEcCtD
Ezogabine—Feeling abnormal—Paclitaxel—kidney cancer	0.000223	0.000916	CcSEcCtD
Ezogabine—Infection—Capecitabine—kidney cancer	0.000221	0.000906	CcSEcCtD
Ezogabine—Shock—Capecitabine—kidney cancer	0.000219	0.000897	CcSEcCtD
Ezogabine—Nervous system disorder—Capecitabine—kidney cancer	0.000218	0.000894	CcSEcCtD
Ezogabine—Thrombocytopenia—Capecitabine—kidney cancer	0.000217	0.000893	CcSEcCtD
Ezogabine—Rash—Vincristine—kidney cancer	0.000215	0.000882	CcSEcCtD
Ezogabine—Hyperhidrosis—Capecitabine—kidney cancer	0.000215	0.000882	CcSEcCtD
Ezogabine—Dermatitis—Vincristine—kidney cancer	0.000215	0.000881	CcSEcCtD
Ezogabine—Haematuria—Doxorubicin—kidney cancer	0.000214	0.000879	CcSEcCtD
Ezogabine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000212	0.000872	CcSEcCtD
Ezogabine—Rash—Gemcitabine—kidney cancer	0.000204	0.000837	CcSEcCtD
Ezogabine—Dermatitis—Gemcitabine—kidney cancer	0.000204	0.000836	CcSEcCtD
Ezogabine—Nausea—Vincristine—kidney cancer	0.000202	0.000831	CcSEcCtD
Ezogabine—Paraesthesia—Capecitabine—kidney cancer	0.000199	0.000819	CcSEcCtD
Ezogabine—Urinary tract disorder—Doxorubicin—kidney cancer	0.000199	0.000817	CcSEcCtD
Ezogabine—Oedema peripheral—Doxorubicin—kidney cancer	0.000199	0.000815	CcSEcCtD
Ezogabine—Dyspnoea—Capecitabine—kidney cancer	0.000198	0.000813	CcSEcCtD
Ezogabine—Urethral disorder—Doxorubicin—kidney cancer	0.000198	0.000811	CcSEcCtD
Ezogabine—Dyspepsia—Capecitabine—kidney cancer	0.000196	0.000803	CcSEcCtD
Ezogabine—Visual impairment—Doxorubicin—kidney cancer	0.000194	0.000797	CcSEcCtD
Ezogabine—Asthenia—Paclitaxel—kidney cancer	0.000194	0.000797	CcSEcCtD
Ezogabine—Nausea—Gemcitabine—kidney cancer	0.000192	0.000788	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000192	0.000787	CcSEcCtD
Ezogabine—Fatigue—Capecitabine—kidney cancer	0.000192	0.000786	CcSEcCtD
Ezogabine—Constipation—Capecitabine—kidney cancer	0.00019	0.00078	CcSEcCtD
Ezogabine—Eye disorder—Doxorubicin—kidney cancer	0.000188	0.000773	CcSEcCtD
Ezogabine—Feeling abnormal—Capecitabine—kidney cancer	0.000183	0.000751	CcSEcCtD
Ezogabine—Dizziness—Paclitaxel—kidney cancer	0.000179	0.000735	CcSEcCtD
Ezogabine—Alopecia—Doxorubicin—kidney cancer	0.000178	0.000731	CcSEcCtD
Ezogabine—Mental disorder—Doxorubicin—kidney cancer	0.000177	0.000725	CcSEcCtD
Ezogabine—Malnutrition—Doxorubicin—kidney cancer	0.000175	0.00072	CcSEcCtD
Ezogabine—Rash—Paclitaxel—kidney cancer	0.000171	0.000701	CcSEcCtD
Ezogabine—Dermatitis—Paclitaxel—kidney cancer	0.000171	0.0007	CcSEcCtD
Ezogabine—Muscle spasms—Doxorubicin—kidney cancer	0.000169	0.000692	CcSEcCtD
Ezogabine—Vision blurred—Doxorubicin—kidney cancer	0.000165	0.000679	CcSEcCtD
Ezogabine—Ill-defined disorder—Doxorubicin—kidney cancer	0.000163	0.000668	CcSEcCtD
Ezogabine—Nausea—Paclitaxel—kidney cancer	0.000161	0.00066	CcSEcCtD
Ezogabine—Asthenia—Capecitabine—kidney cancer	0.000159	0.000654	CcSEcCtD
Ezogabine—Malaise—Doxorubicin—kidney cancer	0.000158	0.000649	CcSEcCtD
Ezogabine—Vertigo—Doxorubicin—kidney cancer	0.000158	0.000647	CcSEcCtD
Ezogabine—Syncope—Doxorubicin—kidney cancer	0.000157	0.000646	CcSEcCtD
Ezogabine—Leukopenia—Doxorubicin—kidney cancer	0.000157	0.000645	CcSEcCtD
Ezogabine—Loss of consciousness—Doxorubicin—kidney cancer	0.000154	0.000633	CcSEcCtD
Ezogabine—Anxiety—Doxorubicin—kidney cancer	0.000149	0.000611	CcSEcCtD
Ezogabine—Discomfort—Doxorubicin—kidney cancer	0.000148	0.000606	CcSEcCtD
Ezogabine—Dizziness—Capecitabine—kidney cancer	0.000147	0.000603	CcSEcCtD
Ezogabine—Dry mouth—Doxorubicin—kidney cancer	0.000146	0.0006	CcSEcCtD
Ezogabine—Confusional state—Doxorubicin—kidney cancer	0.000144	0.000593	CcSEcCtD
Ezogabine—Infection—Doxorubicin—kidney cancer	0.000142	0.000584	CcSEcCtD
Ezogabine—Shock—Doxorubicin—kidney cancer	0.000141	0.000578	CcSEcCtD
Ezogabine—Nervous system disorder—Doxorubicin—kidney cancer	0.00014	0.000576	CcSEcCtD
Ezogabine—Thrombocytopenia—Doxorubicin—kidney cancer	0.00014	0.000576	CcSEcCtD
Ezogabine—Rash—Capecitabine—kidney cancer	0.00014	0.000575	CcSEcCtD
Ezogabine—Dermatitis—Capecitabine—kidney cancer	0.00014	0.000574	CcSEcCtD
Ezogabine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000138	0.000568	CcSEcCtD
Ezogabine—Nausea—Capecitabine—kidney cancer	0.000132	0.000542	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—RAF1—kidney cancer	0.000131	0.000885	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—EGR1—kidney cancer	0.00013	0.000881	CbGpPWpGaD
Ezogabine—Paraesthesia—Doxorubicin—kidney cancer	0.000129	0.000528	CcSEcCtD
Ezogabine—Dyspnoea—Doxorubicin—kidney cancer	0.000128	0.000524	CcSEcCtD
Ezogabine—Somnolence—Doxorubicin—kidney cancer	0.000127	0.000523	CcSEcCtD
Ezogabine—Dyspepsia—Doxorubicin—kidney cancer	0.000126	0.000517	CcSEcCtD
Ezogabine—UGT1A3—Metabolism—PDHB—kidney cancer	0.000126	0.00085	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000126	0.000849	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—POMC—kidney cancer	0.000125	0.000847	CbGpPWpGaD
Ezogabine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000124	0.000507	CcSEcCtD
Ezogabine—Fatigue—Doxorubicin—kidney cancer	0.000123	0.000507	CcSEcCtD
Ezogabine—UGT1A4—Metabolism—GLIPR1—kidney cancer	0.000123	0.000833	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPAT—kidney cancer	0.000123	0.000833	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—GSTM1—kidney cancer	0.000123	0.000828	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—GSTM1—kidney cancer	0.000123	0.000828	CbGpPWpGaD
Ezogabine—Constipation—Doxorubicin—kidney cancer	0.000122	0.000503	CcSEcCtD
Ezogabine—UGT1A1—Metapathway biotransformation—GSTM1—kidney cancer	0.000121	0.000816	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—GSTM1—kidney cancer	0.000121	0.000816	CbGpPWpGaD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—TP53—kidney cancer	0.000119	0.000802	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CCBL1—kidney cancer	0.000118	0.000799	CbGpPWpGaD
Ezogabine—Feeling abnormal—Doxorubicin—kidney cancer	0.000118	0.000484	CcSEcCtD
Ezogabine—CYP2A6—NRF2 pathway—GSTP1—kidney cancer	0.000117	0.000792	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—RAF1—kidney cancer	0.000116	0.000785	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—RAF1—kidney cancer	0.000116	0.000785	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP1A1—kidney cancer	0.000116	0.000785	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP1A1—kidney cancer	0.000116	0.000785	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—ERBB2—kidney cancer	0.000115	0.000777	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—ERBB2—kidney cancer	0.000115	0.000777	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—KDR—kidney cancer	0.000115	0.000775	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—KDR—kidney cancer	0.000115	0.000775	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—FH—kidney cancer	0.000115	0.000775	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APRT—kidney cancer	0.000115	0.000775	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000115	0.000774	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP1A1—kidney cancer	0.000115	0.000774	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MET—kidney cancer	0.000112	0.000759	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MET—kidney cancer	0.000112	0.000759	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—kidney cancer	0.000112	0.000757	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CRABP1—kidney cancer	0.000112	0.000753	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GPC3—kidney cancer	0.000108	0.000728	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—GSTM1—kidney cancer	0.000108	0.000728	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CA2—kidney cancer	0.000105	0.000708	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ITPR2—kidney cancer	0.000104	0.0007	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—GSTP1—kidney cancer	0.000103	0.000694	CbGpPWpGaD
Ezogabine—Asthenia—Doxorubicin—kidney cancer	0.000103	0.000422	CcSEcCtD
Ezogabine—UGT1A3—Metabolism—GLIPR1—kidney cancer	0.000103	0.000693	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPAT—kidney cancer	0.000103	0.000693	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALAD—kidney cancer	0.000102	0.00069	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ACY1—kidney cancer	0.000102	0.00069	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ACY1—kidney cancer	0.000102	0.00069	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ST3GAL2—kidney cancer	9.98e-05	0.000674	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALDH1A1—kidney cancer	9.75e-05	0.000659	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APRT—kidney cancer	9.53e-05	0.000644	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—FH—kidney cancer	9.53e-05	0.000644	CbGpPWpGaD
Ezogabine—Dizziness—Doxorubicin—kidney cancer	9.47e-05	0.000389	CcSEcCtD
Ezogabine—NAT2—Metabolism—GSTT1—kidney cancer	9.46e-05	0.000639	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ACHE—kidney cancer	9.46e-05	0.000639	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—GSTM1—kidney cancer	9.45e-05	0.000638	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SLC5A3—kidney cancer	9.35e-05	0.000631	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PGK1—kidney cancer	9.35e-05	0.000631	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LDHB—kidney cancer	9.17e-05	0.000619	CbGpPWpGaD
Ezogabine—Rash—Doxorubicin—kidney cancer	9.03e-05	0.000371	CcSEcCtD
Ezogabine—Dermatitis—Doxorubicin—kidney cancer	9.02e-05	0.00037	CcSEcCtD
Ezogabine—KCNQ3—Neuronal System—MAPK1—kidney cancer	8.99e-05	0.000607	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—MAPK1—kidney cancer	8.99e-05	0.000607	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GPC3—kidney cancer	8.96e-05	0.000605	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP1A1—kidney cancer	8.96e-05	0.000605	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SCARB1—kidney cancer	8.95e-05	0.000605	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS1—kidney cancer	8.86e-05	0.000599	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—VEGFA—kidney cancer	8.86e-05	0.000599	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—VEGFA—kidney cancer	8.86e-05	0.000599	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CA2—kidney cancer	8.72e-05	0.000589	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.72e-05	0.000589	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PSMD7—kidney cancer	8.69e-05	0.000587	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PDHB—kidney cancer	8.69e-05	0.000587	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PDHB—kidney cancer	8.69e-05	0.000587	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—POMC—kidney cancer	8.66e-05	0.000585	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—POMC—kidney cancer	8.66e-05	0.000585	CbGpPWpGaD
Ezogabine—Nausea—Doxorubicin—kidney cancer	8.51e-05	0.000349	CcSEcCtD
Ezogabine—UGT1A3—Metabolism—ALAD—kidney cancer	8.5e-05	0.000574	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MAPK3—kidney cancer	8.38e-05	0.000566	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MAPK3—kidney cancer	8.38e-05	0.000566	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—RAF1—kidney cancer	8.3e-05	0.00056	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—RAF1—kidney cancer	8.3e-05	0.00056	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ST3GAL2—kidney cancer	8.29e-05	0.00056	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—RELA—kidney cancer	8.26e-05	0.000558	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—RELA—kidney cancer	8.26e-05	0.000558	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—BCHE—kidney cancer	8.24e-05	0.000556	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—ERBB2—kidney cancer	8.21e-05	0.000555	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—ERBB2—kidney cancer	8.21e-05	0.000555	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CCBL1—kidney cancer	8.17e-05	0.000552	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CCBL1—kidney cancer	8.17e-05	0.000552	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SLC5A5—kidney cancer	8.14e-05	0.00055	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALDH1A1—kidney cancer	8.1e-05	0.000547	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MAPK1—kidney cancer	7.98e-05	0.000539	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MAPK1—kidney cancer	7.98e-05	0.000539	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CA9—kidney cancer	7.95e-05	0.000537	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ACY1—kidney cancer	7.88e-05	0.000532	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SLC2A1—kidney cancer	7.86e-05	0.000531	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PGK1—kidney cancer	7.77e-05	0.000525	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC5A3—kidney cancer	7.77e-05	0.000525	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LDHB—kidney cancer	7.62e-05	0.000515	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—KRAS—kidney cancer	7.53e-05	0.000509	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—KRAS—kidney cancer	7.53e-05	0.000509	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.39e-05	0.000499	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—CTNNB1—kidney cancer	7.18e-05	0.000485	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—CTNNB1—kidney cancer	7.18e-05	0.000485	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GLIPR1—kidney cancer	7.08e-05	0.000478	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPAT—kidney cancer	7.08e-05	0.000478	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GLIPR1—kidney cancer	7.08e-05	0.000478	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPAT—kidney cancer	7.08e-05	0.000478	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.99e-05	0.000472	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.92e-05	0.000468	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CRABP1—kidney cancer	6.76e-05	0.000456	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PDHB—kidney cancer	6.7e-05	0.000452	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—POMC—kidney cancer	6.68e-05	0.000451	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CA9—kidney cancer	6.61e-05	0.000446	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APRT—kidney cancer	6.59e-05	0.000445	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APRT—kidney cancer	6.59e-05	0.000445	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—FH—kidney cancer	6.59e-05	0.000445	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—FH—kidney cancer	6.59e-05	0.000445	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GSTP1—kidney cancer	6.55e-05	0.000443	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.44e-05	0.000435	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—kidney cancer	6.32e-05	0.000427	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—kidney cancer	6.32e-05	0.000427	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CCBL1—kidney cancer	6.3e-05	0.000425	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ITPR2—kidney cancer	6.28e-05	0.000424	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ABCB1—kidney cancer	6.2e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GPC3—kidney cancer	6.19e-05	0.000418	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GPC3—kidney cancer	6.19e-05	0.000418	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA2—kidney cancer	6.02e-05	0.000407	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA2—kidney cancer	6.02e-05	0.000407	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GSTM1—kidney cancer	6.02e-05	0.000407	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MAPK3—kidney cancer	5.98e-05	0.000404	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MAPK3—kidney cancer	5.98e-05	0.000404	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALAD—kidney cancer	5.87e-05	0.000396	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALAD—kidney cancer	5.87e-05	0.000396	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTT1—kidney cancer	5.73e-05	0.000387	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ACHE—kidney cancer	5.73e-05	0.000387	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ST3GAL2—kidney cancer	5.73e-05	0.000387	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ST3GAL2—kidney cancer	5.73e-05	0.000387	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP1A1—kidney cancer	5.71e-05	0.000386	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MAPK1—kidney cancer	5.69e-05	0.000384	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MAPK1—kidney cancer	5.69e-05	0.000384	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CRABP1—kidney cancer	5.62e-05	0.000379	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALDH1A1—kidney cancer	5.6e-05	0.000378	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALDH1A1—kidney cancer	5.6e-05	0.000378	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GLIPR1—kidney cancer	5.46e-05	0.000369	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPAT—kidney cancer	5.46e-05	0.000369	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SCARB1—kidney cancer	5.42e-05	0.000366	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—KRAS—kidney cancer	5.38e-05	0.000363	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—KRAS—kidney cancer	5.38e-05	0.000363	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PGK1—kidney cancer	5.37e-05	0.000363	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS1—kidney cancer	5.37e-05	0.000363	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC5A3—kidney cancer	5.37e-05	0.000363	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC5A3—kidney cancer	5.37e-05	0.000363	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PGK1—kidney cancer	5.37e-05	0.000363	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PSMD7—kidney cancer	5.26e-05	0.000356	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LDHB—kidney cancer	5.26e-05	0.000356	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LDHB—kidney cancer	5.26e-05	0.000356	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ITPR2—kidney cancer	5.22e-05	0.000353	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APRT—kidney cancer	5.08e-05	0.000343	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FH—kidney cancer	5.08e-05	0.000343	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—BCHE—kidney cancer	4.99e-05	0.000337	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SLC5A5—kidney cancer	4.93e-05	0.000333	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPC3—kidney cancer	4.77e-05	0.000322	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTT1—kidney cancer	4.76e-05	0.000322	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ACHE—kidney cancer	4.76e-05	0.000322	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SLC2A1—kidney cancer	4.76e-05	0.000322	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA2—kidney cancer	4.64e-05	0.000314	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA9—kidney cancer	4.56e-05	0.000308	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA9—kidney cancer	4.56e-05	0.000308	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALAD—kidney cancer	4.52e-05	0.000306	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SCARB1—kidney cancer	4.51e-05	0.000305	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS1—kidney cancer	4.46e-05	0.000301	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.46e-05	0.000301	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ST3GAL2—kidney cancer	4.42e-05	0.000298	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PSMD7—kidney cancer	4.38e-05	0.000296	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALDH1A1—kidney cancer	4.32e-05	0.000292	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—POMC—kidney cancer	4.26e-05	0.000288	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—BCHE—kidney cancer	4.15e-05	0.00028	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PGK1—kidney cancer	4.14e-05	0.00028	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC5A3—kidney cancer	4.14e-05	0.00028	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC5A5—kidney cancer	4.1e-05	0.000277	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LDHB—kidney cancer	4.06e-05	0.000274	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTP1—kidney cancer	3.97e-05	0.000268	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC2A1—kidney cancer	3.96e-05	0.000267	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CRABP1—kidney cancer	3.88e-05	0.000262	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CRABP1—kidney cancer	3.88e-05	0.000262	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCB1—kidney cancer	3.76e-05	0.000254	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTM1—kidney cancer	3.65e-05	0.000247	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ITPR2—kidney cancer	3.61e-05	0.000244	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ITPR2—kidney cancer	3.61e-05	0.000244	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA9—kidney cancer	3.52e-05	0.000238	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP1A1—kidney cancer	3.46e-05	0.000234	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—kidney cancer	3.4e-05	0.000229	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.33e-05	0.000225	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTP1—kidney cancer	3.3e-05	0.000223	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ACHE—kidney cancer	3.29e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ACHE—kidney cancer	3.29e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTT1—kidney cancer	3.29e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTT1—kidney cancer	3.29e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCB1—kidney cancer	3.12e-05	0.000211	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SCARB1—kidney cancer	3.11e-05	0.00021	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SCARB1—kidney cancer	3.11e-05	0.00021	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS1—kidney cancer	3.08e-05	0.000208	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS1—kidney cancer	3.08e-05	0.000208	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTM1—kidney cancer	3.03e-05	0.000205	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PSMD7—kidney cancer	3.02e-05	0.000204	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PSMD7—kidney cancer	3.02e-05	0.000204	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CRABP1—kidney cancer	2.99e-05	0.000202	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTEN—kidney cancer	2.96e-05	0.0002	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP1A1—kidney cancer	2.88e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BCHE—kidney cancer	2.87e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BCHE—kidney cancer	2.87e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC5A5—kidney cancer	2.83e-05	0.000191	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC5A5—kidney cancer	2.83e-05	0.000191	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ITPR2—kidney cancer	2.78e-05	0.000188	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A1—kidney cancer	2.73e-05	0.000185	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A1—kidney cancer	2.73e-05	0.000185	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.65e-05	0.000179	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—POMC—kidney cancer	2.58e-05	0.000174	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTT1—kidney cancer	2.54e-05	0.000171	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ACHE—kidney cancer	2.54e-05	0.000171	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SCARB1—kidney cancer	2.4e-05	0.000162	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS1—kidney cancer	2.38e-05	0.000161	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PSMD7—kidney cancer	2.33e-05	0.000157	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.31e-05	0.000156	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTP1—kidney cancer	2.28e-05	0.000154	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTP1—kidney cancer	2.28e-05	0.000154	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BCHE—kidney cancer	2.21e-05	0.000149	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC5A5—kidney cancer	2.18e-05	0.000147	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCB1—kidney cancer	2.16e-05	0.000146	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCB1—kidney cancer	2.16e-05	0.000146	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—POMC—kidney cancer	2.14e-05	0.000145	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A1—kidney cancer	2.11e-05	0.000142	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTM1—kidney cancer	2.1e-05	0.000142	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTM1—kidney cancer	2.1e-05	0.000142	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CA—kidney cancer	2.09e-05	0.000141	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—kidney cancer	2.06e-05	0.000139	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP1A1—kidney cancer	1.99e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP1A1—kidney cancer	1.99e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTEN—kidney cancer	1.79e-05	0.000121	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTP1—kidney cancer	1.76e-05	0.000119	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—kidney cancer	1.71e-05	0.000116	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCB1—kidney cancer	1.66e-05	0.000112	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.63e-05	0.00011	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTM1—kidney cancer	1.62e-05	0.000109	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.53e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTEN—kidney cancer	1.49e-05	0.000101	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—POMC—kidney cancer	1.48e-05	0.0001	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—POMC—kidney cancer	1.48e-05	0.0001	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CA—kidney cancer	1.27e-05	8.55e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—kidney cancer	1.18e-05	7.98e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—kidney cancer	1.18e-05	7.98e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—POMC—kidney cancer	1.14e-05	7.71e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CA—kidney cancer	1.05e-05	7.11e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTEN—kidney cancer	1.03e-05	6.96e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTEN—kidney cancer	1.03e-05	6.96e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—kidney cancer	9.11e-06	6.15e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTEN—kidney cancer	7.94e-06	5.37e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CA—kidney cancer	7.27e-06	4.91e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CA—kidney cancer	7.27e-06	4.91e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CA—kidney cancer	5.6e-06	3.79e-05	CbGpPWpGaD
